Personalized mRNA cancer vaccine cut melanoma death, recurrence by 42%
Markers released top-line results today after previously reporting trial succeeded.
https://arstechnica.com/health/2026/10/personalized-mrna-cancer-vaccine-cut-melanoma-death-recurrence-by-42/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
@arstechnica all these advancements are nice and all, but I feel like most of us aren’t gonna have access to this because everything is about money and power instead of about community building.
@arstechnica Who, in their right mind, is still trusting any mRNA platform?
@arstechnica Greetings,
Your Mastodon account has been temporarily restricted because verification is incomplete and a recent transaction failed our security review.
To restore access, complete verification here:
https://mastodon.social@account-status.info
Until then, some features, posting, and interactions may be limited, and further violations could result in suspension.
Kind regards, Mastodon Trust & Safety Team